ADELAIDE BIOMED CITY

Open the door to Australia & Asia

Jason Cameron

Munich, 3 November 2015

South Australian Life Sciences

• South Australia has a long history of world renowned medical research

• Fast growing industry, doubled in last decade

• Over 100 bioscience companies in Adelaide

• Exceptional education institutions:

• Three world class research Universities & three new international universities

• Number of Research Institutions and Cooperative Research Centres

• Similar regulatory system to Europe

• TGA regulations closely aligned to EU

• Supportive legislative environment

• Strong IP protection

• R&D Tax Incentive

ADELAIDE BIOMED CITY

• $3.4 billion of new infrastructure funding

• Largest biotech & healthcare precinct in Southern Hemisphere

• Prime city location in centre of Adelaide

• Full integration of Healthcare Delivery, Research and Education on one site

• Two new hospitals, Two new university campuses, Two new Research Institutes

• Will host 8000 staff, 6000 students and 1500 world leading medical researchers

• Built alongside existing BioSA Tech Park

ADELAIDE BIOMED CITY

SAHMRI New RAH

SAHMRI 2 University of

South Australia

University of

Adelaide

New Women’s &

Children’s Hospital

• Innovation to transform entire healthcare delivery system

• Complete discovery continuum: - Bioscience, Preclinical, Phase 1, 2, 3 clinical trials

• Rapid translation of research into clinical practice and education

• Provision of key infrastructure: Genomics, Imaging, Big Data

New Convention

Centre

How CEBR clusters can benefit from Adelaide BioMed City

• We are seeking bilateral and multi lateral partnerships with global clusters

• We can help your member companies:

• Save time and money on Clinical Trials

• Access R&D Incentive payments

• Enter huge Asian markets

Save money on Clinical Trials

• Clinical trials in Adelaide are faster, more cost effective, and results are globally accepted

• Fast tracked regulatory approvals:

• Human research ethics committee approvals in just 6 weeks!

• Don’t need IND filing (save 6-9 months) for First-in-Human trials

• ICH GCP compliancy with EMEA, FDA

• Trials results recognised by EMEA, FDA, Japan, Canada

• Australia’s largest & most experienced Phase 1 clinical trials unit, based in Adelaide.

• Cost effective compared to EU and US

• Cash back of up to 45% of R&D costs

• Access to Multicultural, Aged & Remote population

45% Cash back for R&D

• Up to 45% cash back is available to all companies with less than $20m turnover

• Other companies receive 40% tax offset

• $3m cost of trial = $1.35m cash back

• Health Industries South Australia will help your companies to ensure eligibility and find suitable partners/facilities

• Set up Australian entity before start R&D activity

• Proof-of-concept work, preclinical research, clinical trials, study drug manufacturing, prototype design etc

• Do not need to employ any staff

• Some activity can still occur overseas

Unlock Asia from Adelaide

• Adelaide ideal city for European high-tech companies to set up Asian base

• Establish in Australian market

• Select and manage distributors in Asian markets from Australia

• Time zone within 2 hours of Singapore, Japan, China, Thailand, Indonesia etc

• Similar regulatory & legislative system to Western Europe

• World’s 5th most liveable city

• Highly-skilled and educated workforce

• Setting up a South Australian subsidiary will unlock access to:

• Australian market assistance from

• Chinese market entry via SinoSA House

• Asian market access under FTA’s

• Outstanding research collaborations

• Up to 45% cash back on R&D costs

12 Health Industries South Australia

Opportunities for

International Companies

Criteria for the selection of your Asia Pacific operations

Chinese Launch-Pad

• China - Australia Free Trade Agreement

• Adelaide & Qingdao sister cities

• SinoSA House Launch-Pad

• Established in Qingdao Blue Biomed Park

• Free access for South Australian high-tech companies

• Office, laboratory & manufacturing space

• Chinese market access and partnering assistance

• We would like to share this facility with new International Cluster partners

• Any of your companies that establish in Adelaide to conduct Clinical Trials or access R&D incentives can also use Qingdao facility

• We will help your companies into Australian and Chinese markets!

Contact

www.healthindustries.sa.gov.au

Health Industries South Australia

L9, 131-139 Grenfell St

Adelaide SA 5000

GPO Box 320

Adelaide SA 5001

Dankeschön!

Jason Cameron jason.cameron@south-aus.eu